It was somewhat surprising to find that a relatively high percentage of tumours (80%) had PTEN gene loss (defined as ⩾20% of cells with <2 copies of PTEN), and that relatively subtle PTEN loss was associated with significantly shorter PFS and OS. This evidence concerns the gene PTEN and neoplasm.